Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M

Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M

Submitted by admin on July 23, 2018 - 10:24pm
Source: 
Xconomy
News Tags: 
Sangamo BioSciences
M&A
TxCell
autoimmune disease
cell therapy
Headline: 
Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M
snippet: 


Sangamo Biosciences has acquired French biotech TxCell, adding an experimental technology with the potential to treat autoimmune diseases with cell therapy.

Do Not Allow Advertisers to Use My Personal information